Syra Health Overview
Valuation check: SYRA's P/E ratio is 88.89, above the sector sector average of 33.83.
Get informed when a big investor buys or sells
+ Follow88.89
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Syra Health (SYRA) currently reports a P/E ratio of 88.89. That is above the sector sector average of 33.83. Use the charts on this page to explore Syra Health's P/E ratio history and peer comparisons.
Syra Health's P/E ratio of 88.89 is higher than the its sector sector average of 33.83. That is roughly 162.8% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates Syra Health's market price to a fundamental measure such as earnings, sales, or book value. At 88.89, SYRA can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of 88.89, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 33.83. From there, open related valuation or income-statement pages for Syra Health, and consider following SYRA for alerts when major investors trade the stock.
